Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today’s conference call may be recorded.
Esperion Therapeutics Inc. (ESPR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Seas Capital Sina Toussi | 6,230,871 | $13,707,916 | -6% | 1.18% |
| 2. | 10,861,000 | $10,463,770 | 0.11% | ||
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 3,616,200 | $7,955,640 | +1% | 0.01% |
| 4. | 8,000,000 | $7,770,000 | 3.71% | ||
| 5. | Indaba Capital Management Derek C. Schrier | 3,000,000 | $6,600,000 | 3.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.57 | 23,091 | Director | 36,500 | 2023-05-11 | Filing | |
| $1.49 | 8,409 | Director | 13,409 | 2023-05-10 | Filing | |
| $1.50 | 8,111 | Director | 8,111 | 2023-05-10 | Filing | |
| $1.26 | 20,000 | Officer, Director | 312,816 | 2023-05-09 | Filing | |
| $7.46 | 1,000 | Officer | 54,024 | 2022-08-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.87 | 239 | Officer | 159,759 | 2025-02-19 | Filing | |
| $1.86 | 11 | Officer | 240,671 | 2025-02-19 | Filing | |
| $2.27 | 9 | Officer | 240,682 | 2025-01-17 | Filing | |
| $2.26 | 123 | Officer | 159,998 | 2025-01-17 | Filing | |
| $2.42 | 3,245 | Officer | 240,691 | 2024-12-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 24,482,258 | $53,860,968 | 0.26% | |
| 2. | 14,235,423 | $31,317,931 | 0% | |
| 3. | 11,715,748 | $25,774,646 | 0% | |
| 4. | 9,944,064 | $21,876,941 | 0.42% | |
| 5. | 6,309,377 | $13,880,631 | 0% |
News See All
7 Best NASDAQ Stocks Under $5
A Yahoo Finance report on September 28 reveals that consumers are beginning to feel the effects of a cooling labor market, according to the latest Consumer Confidence Index, which shows a narrowing gap...
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2024 Earnings Call Transcript
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2024 Earnings Call Transcript August 12, 2024Esperion Therapeutics, Inc. misses on earnings expectations.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript
Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.00032, expectations were $-0.17.
11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in.
5 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the five best small cap pharma stocks to invest in.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript
Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.53. Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript
Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.53. Esperion Therapeutics, Inc.
12 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 12 best medical stocks to buy under $10.
Should You Sell Esperion Therapeutics (ESPR)?
Tourlite Capital Management, an investment management firm, released its fourth quarter 2023 investor letter, a copy of which can be downloaded here.
Billionaire Hedge Funds
